Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term inhaled dry powder mannitol in cystic fibrosis
2007-001412-23Phase 3Completed
- Sponsor
- Pharmaxis
- Start
- Jul 2007
- Modality
- Small Molecules, Inhalation Devices → Device-based Delivery → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 3 trial of Bronchitol in cystic fibrosis (CF) (2 arms), sponsored by Pharmaxis. Primary endpoint: Change in absolute FEV1. Started Jul 2007; status: completed.
02
Drugs
Bronchitol
03
Conditions
cystic fibrosis (CF)
Beyond the preview
Go deeper on 2007-001412-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-001412-23.